The Quest for a Medical Treatment of Aortic Stenosis: Putative Therapeutic Targets - European Medical Journal

The Quest for a Medical Treatment of Aortic Stenosis: Putative Therapeutic Targets

Download PDF
*Magnus Bäck

No potential conflict of interest.

EMJ Cardiol. ;2:78-86. DOI/10.33590/emjcardiol/10310193.
Echocardiography, Inflammation, leukotrienes, valvular heart disease

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


Aortic stenosis (AS), i.e. calcification and obstruction of the aortic valve (AV), is the most common type of valvular heart disease. The therapeutic options for AS are currently limited to either AV replacement surgery or transcatheter AV implantation. In contrast, no medical treatment has proven effective in slowing the process of valve calcification. The molecular and cellular pathophysiology of AS is an active and complex process, with components of inflammation, lipid accumulation, valvular remodelling, dystrophic calcification, oxidative stress, apoptosis, and heterotopic ossification. These pathways contain several potential targets for medical treatment, which are discussed in the present review. These include the targeting of lipids and lipoproteins, inflammation, and calcification pathways, which have been explored in experimental, epidemiological, and prospective studies. However, further mechanistic studies and prospective trials are needed to better understand the pathophysiology of AS and to lead to new therapeutic strategies for the prevention, or at least the delay, of either surgical or transcatheter valve implantations.

Please view the full content in the pdf above.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally